Echinocandin Antifungal [EPC]

5847 reported adverse events

Drugs of this class: ANIDULAFUNGIN MICAFUNGIN MICAFUNGIN SODIUM REZAFUNGIN

These side effects are most commonly reported by patients taking drugs of the Echinocandin Antifungal [EPC] class:

#	Side effect	Count
0	DRUG INEFFECTIVE	917
1	OFF LABEL USE	514
2	PYREXIA	468
3	SEPSIS	351
4	FEBRILE NEUTROPENIA	347
5	MULTIPLE ORGAN DYSFUNCTION SYNDROME	308
6	PNEUMONIA	305
7	SEPTIC SHOCK	270
8	DIARRHOEA	264
9	PRODUCT USE IN UNAPPROVED INDICATION	249

See all common reactions for Echinocandin Antifungal [EPC]

Drugs of the Echinocandin Antifungal [EPC] class are most commonly taken among patients reporting these side effects:

#	Side effect	Count	Frequency
0	PRE-ENGRAFTMENT IMMUNE REACTION	37	0.6379
1	GEOTRICHUM INFECTION	44	0.2558
2	TRICHOSPORON INFECTION	42	0.1265
3	SCEDOSPORIUM INFECTION	34	0.0720
4	FUSARIUM INFECTION	35	0.0707
5	FUNGAEMIA	75	0.0613
6	CEREBRAL ASPERGILLOSIS	26	0.0533
7	SYSTEMIC MYCOSIS	43	0.0501
8	ENTEROCOCCAL SEPSIS	34	0.0475
9	ACUTE GRAFT VERSUS HOST DISEASE IN LIVER	28	0.0452

See all enriched reactions for Echinocandin Antifungal [EPC]